McKinsey’s $650 Million Settlement Marks a Dark Chapter in Corporate Malfeasance; Senior Partner Faces Obstruction Charges
In a damning chapter in the annals of corporate malfeasance to date, McKinsey & Company—the vaunted consulting powerhouse—has agreed to pay $650 million to resolve U.S. Department of Justice (DOJ) investigations into its role in fueling the opioid epidemic. With this settlement, McKinsey becomes the first consulting firm to face criminal charges for advising a client, Purdue Pharma L.P., on activities that significantly contributed to a public health catastrophe of staggering proportions.